HIGHLIGHTS
- who: . and collaborators from the University of Verona, Italy have published the paper: Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report, in the Journal: (JOURNAL)
- what: The authors aimed to examine and briefly summarize the significant DDIs observed between antithrombotic and HCV antiviral drugs.
SUMMARY
Reduced levels of factors II, IX, XI, and XII are typical of liver cirrhosis and are associated with increased bleeding risk (Scudiero et_al, 2020). Antithrombotic drugs increase the risk of bleeding especially in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.